Concepedia

Author

Diana Griffith

Portland VA Medical Center

Also Known As

D J Griffith, D. Griffith, D. J. Griffith, DIANA J. GRIFFITH, Diana Griffith, Diana J. Griffith

44

Publications

6.6K

Citations

16

H-Index

30

Concepts

All Affiliations

Portland VA Medical CenterOregon Health & Science UniversityBrigham and Women's HospitalDana-Farber Cancer Institute
DG

About

Diana Griffith is an author at Portland VA Medical Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

568

2

Cell Biology

5

5

249

3

Pathology

4

4

508

4

Immunology

2

2

177

5

Molecular Genetics

1

1

319

Diana Griffith

×

17

Publications

5.8K

Citations

15

H-Index

YearCitations

<i>PDGFRA</i> Activating Mutations in Gastrointestinal Stromal Tumors

Michael C. Heinrich, Christopher L. Corless, Anette Duensing,

Science

2003

2.3K

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

Michael C. Heinrich, Diana Griffith, Brian Druker,

Blood

2000

1.1K

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless,

Journal of Clinical Oncology

2008

799

Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies

Marcus M. Schittenhelm, Sharon Shiraga, Arin Schroeder,

Cancer Research

2006

466

KIT Mutations Are Common in Testicular Seminomas

Kathleen Kemmer, Christopher L. Corless, Jonathan A. Fletcher,

American Journal Of Pathology

2004

319

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

Michael C. Heinrich, Diana Griffith, Arin McKinley,

Clinical Cancer Research

2012

218

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Kevin Yee, A O’Farrell, Beverly D. Smolich,

Blood

2002

164

Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-<i>kit</i>Proto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells

Ashlee V. Moses, Michael A. Jarvis, Camilo Raggo,

Journal of Virology

2002

150

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

Michael C. Heinrich, Diana Griffith, Brian Druker,

Blood

2000

91

Sorafenib Inhibits Many Kinase Mutations Associated with Drug-Resistant Gastrointestinal Stromal Tumors

Michael C. Heinrich, Adrián Mariño‐Enríquez, Ajia Presnell,

Molecular Cancer Therapeutics

2012

76

Page 1